Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases
- PMID: 16265128
- DOI: 10.1038/ncpgasthep0090
Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases
Abstract
Adipose tissue has long been regarded as a passive type of connective tissue that stores energy as triglycerides and releases energy as free fatty acids, however, this point of view has now changed. The wide variety of products expressed and secreted by adipose tissue, such as adiponectin, leptin, and resistin, mean that the total adipose tissue mass can be defined as a real endocrine organ. The anatomic, metabolic and biochemical characteristics of visceral adipose tissue make it interesting in the context of intestinal and mesenteric diseases. These characteristics include increased lipolysis, venous drainage via the portal vein and local glucocorticoid excess owing to the specific expression of 11-beta-hydroxysteroid-dehydrogenase type 1. In this review, the role of the visceral adipose tissue and its secretory products in intestinal and mesenteric diseases is systematically reviewed, with special focus on 'creeping fat' in Crohn's disease and mesenteric panniculitis.
Similar articles
-
Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.Nat Clin Pract Gastroenterol Hepatol. 2005 Jun;2(6):273-80. doi: 10.1038/ncpgasthep0186. Nat Clin Pract Gastroenterol Hepatol. 2005. PMID: 16265231 Review.
-
Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.Subcell Biochem. 2007;42:63-91. Subcell Biochem. 2007. PMID: 17612046 Review.
-
Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.Vitam Horm. 2006;74:443-77. doi: 10.1016/S0083-6729(06)74018-3. Vitam Horm. 2006. PMID: 17027526 Review.
-
Adipocytokines - novel link between inflammation and vascular function?J Physiol Pharmacol. 2006 Dec;57(4):505-28. J Physiol Pharmacol. 2006. PMID: 17229978 Review.
-
Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment.J Gastroenterol Hepatol. 2006 Sep;21(9):1412-8. doi: 10.1111/j.1440-1746.2006.04300.x. J Gastroenterol Hepatol. 2006. PMID: 16911685
Cited by
-
Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes.Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5207-12. doi: 10.1073/pnas.0600821103. Epub 2006 Mar 20. Proc Natl Acad Sci U S A. 2006. PMID: 16549770 Free PMC article.
-
Visceral adiposity, insulin resistance and cancer risk.Diabetol Metab Syndr. 2011 Jun 22;3:12. doi: 10.1186/1758-5996-3-12. Diabetol Metab Syndr. 2011. PMID: 21696633 Free PMC article.
-
The role of physical exercise in inflammatory bowel disease.Biomed Res Int. 2014;2014:429031. doi: 10.1155/2014/429031. Epub 2014 Apr 30. Biomed Res Int. 2014. PMID: 24877092 Free PMC article. Review.
-
Serum adipokines in inflammatory bowel disease.World J Gastroenterol. 2014 Jun 14;20(22):6912-7. doi: 10.3748/wjg.v20.i22.6912. World J Gastroenterol. 2014. PMID: 24944482 Free PMC article.
-
Immunopathogenesis of IBD: current state of the art.Nat Rev Gastroenterol Hepatol. 2016 Jan;13(1):13-27. doi: 10.1038/nrgastro.2015.186. Epub 2015 Dec 2. Nat Rev Gastroenterol Hepatol. 2016. PMID: 26627550 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical